Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118793 · ClinicalTrials.gov registry record
Pilot Study on the Effect of High Clopidogrel Maintenance Dosing
A clinical trial, sponsored by Scripps Health.
- Completed
- Registry status
- 41
- Enrollment target
NCT01118793: Completed study, sponsored by Scripps Health.
NCT01118793 is a clinical trial that has completed, run by Scripps Health. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01118793 has completed, sponsored by Scripps Health.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This is a Scripps pilot study on the effect of high clopidogrel maintenance dosing and its relationship to cytochrome P450 2C19 polymorphism status \[STSI/CTSA\].
Interventions
- DRUG Clopidogrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-05 |
What the finished NCT01118793 record still lists
NCT01118793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Clopidogrel is the first listed.
NCT01118793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01118793 about?
NCT01118793 is a clinical study titled "Pilot Study on the Effect of High Clopidogrel Maintenance Dosing". This is a Scripps pilot study on the effect of high clopidogrel maintenance dosing and its relationship to cytochrome P450 2C19 polymorphism status \[STSI/CTSA\].
What is the current status of trial NCT01118793?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2008-12. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01118793?
The interventions under investigation include: Clopidogrel (DRUG).
Who is sponsoring clinical trial NCT01118793?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia